We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $2.72B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
+19.43%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$1.75B
AUM Growth
+$77.9M
Cap. Flow
-$78.7M
Cap. Flow %
-4.49%
Top 10 Hldgs %
55.92%
Holding
150
New
22
Increased
25
Reduced
39
Closed
26

Top Buys

Rank Stock Value
1
PTON icon
Peloton Interactive
PTON
+$15.1M
2
TRML
Tourmaline Bio
TRML
+$10.2M
3
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$6.91M
4
EHTH icon
eHealth
EHTH
+$6.1M
5
CONN
Conn's Inc.
CONN
+$6.03M

Top Sells

Rank Stock Value
1
ESTA icon
Establishment Labs
ESTA
+$20.3M
2
SLNO
Soleno Therapeutics
SLNO
+$20.2M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$19.5M
4
LXFR icon
Luxfer Holdings
LXFR
+$10.1M
5
CYTK icon
Cytokinetics
CYTK
+$9.19M

Sector Composition

Rank Sector Weight
1 Healthcare 36.87%
2 Consumer Discretionary 8.07%
3 Financials 4.11%
4 Communication Services 3.43%
5 Technology 2.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VMD icon
26
Viemed Healthcare
VMD
$355M
$14.6M 0.84%
1,550,122
-402,246
-21% -$3.45M
DXPE icon
27
DXP Enterprises
DXPE
$2.99B
$14.5M 0.83%
269,806
+67,977
+34% +$2.56M
ABVX
28
Abivax
ABVX
$11.1B
$14.4M 0.83%
1,010,034
– –
ZVRA icon
29
Zevra Therapeutics
ZVRA
$682M
$14.2M 0.81%
2,453,405
– –
DYN icon
30
Dyne Therapeutics
DYN
$4.95B
$12.4M 0.71%
435,256
-207,533
-32% -$4.69M
RSVR
31
Reservoir Media
RSVR
$656M
$12.3M 0.7%
1,550,797
– –
EHTH icon
32
eHealth
EHTH
$40.4M
$11.5M 0.66%
1,911,821
+920,000
+93% +$6.1M
SNDX icon
33
Syndax Pharmaceuticals
SNDX
$1.82B
$11.1M 0.63%
465,259
+100,000
+27% +$2.23M
AURA icon
34
Aura Biosciences
AURA
$796M
$10.4M 0.59%
1,321,860
– –
PTON icon
35
CALL
Peloton Interactive
PTON
$2.42B
$10.3M 0.59%
2,400,000
+1,220,000
+103% +$6.02M
NPCE icon
36
Neuropace
NPCE
$507M
$10.3M 0.59%
778,260
-395,417
-34% -$5.64M
GDEN
37
DELISTED
Golden Entertainment
GDEN
$9.92M 0.57%
269,267
-22,182
-8% -$821K
ASRT
38
DELISTED
Assertio
ASRT
$8.89M 0.51%
618,056
+110,093
+22% +$1.5M
PAYO icon
39
Payoneer
PAYO
$2.4B
$8.85M 0.51%
1,821,426
+74,022
+4% +$361K
SVRA icon
40
Savara
SVRA
$1.17B
$8.65M 0.49%
1,737,410
+749,507
+76% +$3.62M
UNCY icon
41
Unicycive Therapeutics
UNCY
$138M
$8.64M 0.49%
333,559
-10,259
-3% -$124K
RMR icon
42
The RMR Group
RMR
$335M
$8.3M 0.47%
345,792
-58,271
-14% -$1.46M
IMTX icon
43
Immatics
IMTX
$1.33B
$8.28M 0.47%
787,974
-625,982
-44% -$7.3M
ILPT
44
Industrial Logistics Properties Trust
ILPT
$583M
$8.07M 0.46%
1,881,132
-111,687
-6% -$454K
VTGN icon
45
VistaGen Therapeutics
VTGN
$11.7M
$8.01M 0.46%
1,517,696
-299,034
-16% -$1.44M
RZLT icon
46
Rezolute
RZLT
$451M
$7.71M 0.44%
3,022,947
+1,485,240
+97% +$2.11M
NDLS icon
47
Noodles & Co
NDLS
$96M
$7.7M 0.44%
504,166
+36,095
+8% +$705K
CLRB icon
48
Cellectar Biosciences
CLRB
$20.8M
$7.46M 0.43%
62,444
+17,425
+39% +$1.89M
LXFR icon
49
Luxfer Holdings
LXFR
$457M
$7.11M 0.41%
685,253
-1,124,392
-62% -$10.1M
ENVA icon
50
CALL
Enova International
ENVA
$6.29B
$6.85M 0.39%
109,000
– –
1
2
3 4 5

Similar funds

TAM
Timucuan Asset Management Jacksonville, Florida $2.72B AUM 4.95% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
NB
Nicolet Bankshares Green Bay, Wisconsin $2.71B AUM 17.55% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
BCM
Bowie Capital Management Richardson, Texas $2.71B AUM 5.42% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return

Nantahala Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Nantahala Capital Management held 150 positions worth $1.75B, up 4.7% from $1.67B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Nantahala Capital Management withdrew a net $78.7M in Q1 2024, closing 26 positions and reducing 39 holdings. Its most notable exit was iShares Russell 2000 ETF, an estimated $19.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Nantahala Capital Management opened a new position in Eagle Pharmaceuticals, Inc. worth $6.6M.

  • Nantahala Capital Management's largest Q1 2024 buy was Eagle Pharmaceuticals, Inc.: 1,258,762 shares worth $6.6M.
  • Nantahala Capital Management added most to Peloton Interactive in Q1 2024, an estimated $15.1M increase.
  • Nantahala Capital Management's biggest Q1 2024 reduction was Establishment Labs, cutting an estimated $20.3M.
  • Nantahala Capital Management fully exited iShares Russell 2000 ETF in Q1 2024, selling an estimated $19.5M.
  • Nantahala Capital Management's ten largest holdings make up 56% of its $1.75B portfolio in Q1 2024.
  • Nantahala Capital Management opened 22 new positions and closed 26 in Q1 2024.
  • Nantahala Capital Management's portfolio value rose 4.7% quarter-over-quarter to $1.75B.

Based on Nantahala Capital Management's 13F filing for Q1 2024, filed 15 May 2024.